Mayo Clinic collaborates with Ultromics to rapidly assess patients diagnosed with COVID-19

Mayo Clinic collaborates with Ultromics to rapidly assess patients diagnosed with COVID-19

Press releases may be edited for formatting or style | May 11, 2020 Artificial Intelligence
A joint UK-US research team is applying a pioneering artificial intelligence system to map for the first time how the COVID-19 virus attacks the heart with such deadly impact.

The coronavirus has been found to kill more than one in ten victims with heart disease and also to significantly weaken the hearts of other sufferers.

This week, British health-tech company Ultromics and Mayo Clinic in the US will use AI software, EchoGo Core, to analyze echocardiograms of COVID-19 victims, for clues about how the virus affects the human cardiovascular system.

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

Their findings will produce, for the first time, a map of the 'novel cardiac features' of COVID-19 and help physicians rapidly triage and treat high-risk patients, potentially saving countless lives.

You Must Be Logged In To Post A Comment